About Rentschler Biopharma
Rentschler Biopharma is a company based in Laupheim (Germany) founded in 1927.. Rentschler Biopharma offers products and services including Analytical Development, Process Development, cGMP Manufacturing, Formulation Development, and Regulatory Affairs Consulting. Rentschler Biopharma operates in a competitive market with competitors including Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others.
- Headquarter Laupheim, Germany
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rentschler Biopharma Se
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$301.27 K (USD), Grant
Jan 01, 2015
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rentschler Biopharma
Rentschler Biopharma offers a comprehensive portfolio of products and services, including Analytical Development, Process Development, cGMP Manufacturing, Formulation Development, and Regulatory Affairs Consulting. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides analysis for biopharmaceutical quality and safety.
Optimizes production processes for biopharmaceuticals.
Ensures compliant manufacturing of biopharmaceutical products.
Develops formulations for biopharmaceutical stability.
Offers guidance on regulatory compliance for biopharmaceuticals.
Funding Insights of Rentschler Biopharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $301,268
-
First Round
First Round
(01 Jan 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Grant - Rentschler Biopharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Rentschler Biopharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rentschler Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rentschler Biopharma Comparisons
Competitors of Rentschler Biopharma
Rentschler Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Mammalian cell culture biologics are developed through contract research services.
|
|
| domain | founded_year | HQ Location |
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
|
|
| domain | founded_year | HQ Location |
Contract manufacturing solutions for biologics are provided to Asian companies.
|
|
| domain | founded_year | HQ Location |
Drug substance development, analytical, and compliance services are provided.
|
|
| domain | founded_year | HQ Location |
Biologics development and GMP manufacturing services are offered.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rentschler Biopharma
Frequently Asked Questions about Rentschler Biopharma
When was Rentschler Biopharma founded?
Rentschler Biopharma was founded in 1927 and raised its 1st funding round 88 years after it was founded.
Where is Rentschler Biopharma located?
Rentschler Biopharma is headquartered in Laupheim, Germany. It is registered at Laupheim, Baden-wurttemberg, Germany.
Who is the current CEO of Rentschler Biopharma?
Frank Mathias is the current CEO of Rentschler Biopharma.
What does Rentschler Biopharma do?
Rentschler Biopharma is a full-service contract development and manufacturing organization (CDMO) focused on the development and manufacturing of biopharmaceuticals. The company offers bioprocess development, biomanufacturing associated consulting services. The bioprocess development services include cell line, process, formulation analytical development. It has a proprietary technology platform TurboCell for mammalian cell line development. It has cGMP facility for biomanufacturing services. Also offers regulatory support project management services related to biopharmaceutical development. It has strategic partnerships with Leukocare AG Rentschler Fill Solutions to offer various CDMO services to the clients. The company has experience and expertise in the development of interferons, antibodies, fusion proteins and enzymes.
Who are the top competitors of Rentschler Biopharma?
Rentschler Biopharma's top competitors include Avid Bioservices, Bionova Scientific and Just Biotherapeutics.
What products or services does Rentschler Biopharma offer?
Rentschler Biopharma offers Analytical Development, Process Development, cGMP Manufacturing, Formulation Development, and Regulatory Affairs Consulting.